NAIHC’s Dr. Mahlberg Advising Stevia Corp’s Real Hemp, Indianapolis, Sept. 24, 2015 – NAIHC Board Member Dr. Paul Mahlberg has been appointed as an advisor to healthcare company Stevia Corp’s Real Hemp subsidiary which focuses on commercializing industrial hemp.

As part of the appointment, Real Hemp has made Dr. Mahlberg’s 30 years of ground breaking cannabis research available in a searchable cannabis database. Previously, these research papers were only available from the North American Industrial Hemp Council’s NAIHC research web pages.

His cannabis research focuses specifically on glandular trichome development and has been referenced in thousands of cannabis and hemp articles and publications over the years. The research also resulted in some of the most important discoveries about the cannabis plant that are still applied today by some of the most successful cannabis grow operations and industrial hemp farms in the world.

Dr. Mahlberg is known as one of the world’s leading researchers of the cannabis plant. He obtained one of only two Drug Enforcement Administration (DEA) Schedule 1 research licenses to pursue studies on cannabis in the United States spanning a period of 33 years from 1970-2003. During that time, he accumulated one of the most extensive seed banks in the world with over 200 strains (including landrace varieties) of cannabis from worldwide sources, which were cultivated in secure greenhouses.

Dr. Mahlberg is a Professor Emeritus of Indiana University and was an active professor in the Botany department of the University until 1994 after which he continued his research on cannabis with visiting faculty and maintained his laboratory until 2003. Dr. Mahlberg received his Ph.D. in Botany from the University of California, Berkley and his M.S. and B.S. degrees in Botany from the University of Wisconsin, Madison.

George Blankenbaker, President of Stevia Corp commented, “We are fortunate to have Dr. Mahlberg on our advisory panel and it is a great honor that he chose our company to make his valuable research available to scientists, growers and consumers. At the time that Dr. Mahlberg was conducting his research, he was a pioneer in a field of study that did not have the full understanding and support of the general public, politicians and other scientists. Now that the true value of the cannabis plant is starting to be known and understood, there is considerable interest by many parties to have access to such research. We are thrilled to be able facilitate the expansion of knowledge of this important plant in support of this important industry.”

The research library contains a total of 37 searchable publications that can be viewed at

For further information on Dr. Mahlberg, cannabis, Stevia Corp, and Real Hemp, see the Stevia press release and see Dr. Mahlberg’s full biography.